Table of Content




1. Executive Summary


2. Global Intravenous Immunoglobulin Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Intravenous Immunoglobulin Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Intravenous Immunoglobulin Market by Application
3.3.1: Hypogammaglobulinemia
3.3.2: CIPD
3.3.3: Immunodeficiency Diseases
3.3.4: Congenital AIDS
3.3.5: Chronic Lymphocytic Leukemia
3.3.6: Myasthenia Gravis
3.3.7: Multifocal Motor Neuropathy
3.3.8: Kawasaki Disease
3.3.9: Guillain-Barre Syndrome

3.4: Global Intravenous Immunoglobulin Market by Distribution Channel
3.4.1: Intravenous
3.4.2: Subcutaneous

3.5: Global Intravenous Immunoglobulin Market by End Use
3.5.1: Hospitals
3.5.2: Homecare
3.5.3: Specialty Clinics
3.5.4: Others


3.6: Global Intravenous Immunoglobulin Market by Form
3.6.1: Liquid
3.6.2: Lyophilized


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Intravenous Immunoglobulin Market by Region
4.2: North American Intravenous Immunoglobulin Market
4.2.2: North American Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others


4.3: European Intravenous Immunoglobulin Market
4.3.1: European Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
4.3.2: European Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others


4.4: APAC Intravenous Immunoglobulin Market
4.4.1: APAC Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
4.4.2: APAC Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others


4.5: ROW Intravenous Immunoglobulin Market
4.5.1: ROW Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
4.5.2: ROW Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Application
6.1.2: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Intravenous Immunoglobulin Market by End Use
6.1.4: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Form
6.1.5: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Region

6.2: Emerging Trends in the Global Intravenous Immunoglobulin Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Intravenous Immunoglobulin Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Immunoglobulin Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Baxter
7.2: Bayer
7.3: Merck
7.4: Biotest
7.5: Top Bio
7.6: CSL
7.7: Octapharma
7.8: Grifols
7.9: Kedrion
7.10: Takeda Pharmaceuical